Mankind Pharma (NSE:MANKIND) filed an exchange disclosure on 19 August 2026 confirming that newspaper advertisements notifying shareholders of a Postal Ballot were published that day in Financial Express (English) and Jansatta (Hindi), following an earlier intimation dated 18 August 2026.
Key Highlights
- Newspaper advertisements confirming dispatch of the Postal Ballot Notice were published on 19 August 2026 in Financial Express (English) and Jansatta (Hindi) simultaneously.
- The disclosure was made under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, as a follow-up to the intimation filed on 18 August 2026.
- The Postal Ballot process is being conducted in accordance with Sections 108 and 110 of the Companies Act, 2013, read with the rules framed thereunder.
- The filing was submitted by Hitesh Kumar Jain, Company Secretary and Compliance Officer of Mankind Pharma Limited.
About the Company
Mankind Pharma Limited (NSE:MANKIND) is a New Delhi-headquartered pharmaceutical company listed on the NSE, with its registered office at Okhla Industrial Estate, Phase 3. The company manufactures and markets branded generic medicines across therapeutic segments including cardiology, anti-infectives, gastroenterology, and gynaecology, distributing products through an extensive pan-India field force and retail network.
Announcement in Detail
The exchange filing, submitted by Company Secretary Hitesh Kumar Jain, confirmed that Mankind Pharma published Postal Ballot Notice advertisements in two widely circulated newspapers on 19 August 2026: Financial Express in English and Jansatta in Hindi. The advertisements informed shareholders about the dispatch of the Postal Ballot Notice and provided requisite details as required under applicable provisions of the Companies Act, 2013.
The intimation references Sections 108 and 110 of the Companies Act, 2013, which govern voting through electronic means and the postal ballot process respectively. The publication follows an earlier intimation to the exchanges dated 18 August 2026 regarding the same Postal Ballot Notice. The filing does not specify the resolution or resolutions being put to shareholders for voting through this postal ballot process.
Impact on Investors
Investors will note that the newspaper publication marks a formal procedural step in the postal ballot process, signalling that the voting window is either open or will open shortly. Shareholders should review the full Postal Ballot Notice to understand the specific resolution or resolutions on which their vote is being sought, as the exchange filing itself does not disclose the subject matter of those resolutions.
The filing shows this is a compliance and disclosure action rather than a substantive corporate decision. Shareholders will observe that the outcome of any resolution passed through postal ballot is binding on the company, making the notice document the key reference for understanding what is being decided and how to participate in the voting process.
Sector / Market Context
India's pharmaceutical sector remains one of the more regulated industries under SEBI and Ministry of Corporate Affairs frameworks, with listed pharma companies required to maintain strict disclosure timelines for shareholder voting events. The use of postal ballot and electronic voting under the Companies Act, 2013 framework ensures broader retail shareholder participation in governance decisions beyond physical meetings.